Literature DB >> 11719261

PQBP-1 (Np/PQ): a polyglutamine tract-binding and nuclear inclusion-forming protein.

H Okazawa1, M Sudol, T Rich.   

Abstract

Polyglutamine(Q) tract binding protein-1 (PQBP-1) was isolated on the basis of its interaction with polyglutamine tracts and localizes predominantly to the nucleus where it suppresses transcriptional activation by a neuron-specific transcription factor, Brn-2. Its C-terminal domain is highly conserved and binds to a component of the spliceosome. PQBP-1 possesses unique repetitive sequences that may fold as polar zippers. Interestingly, PQBP-1 also forms nuclear inclusion bodies, which are similar to those nucleated by the protein products of polyglutamine disease genes. Furthermore, because PQBP-1 is highly conserved in simple animal metazoans and plants (Caenorhabditis elegans and Arabidopsis), it may perform a basic function in cells. By the same token, disruption of the basic function could be critical to the disease process. Collectively, PQBP-1 might be a candidate molecule involved in the pathology of polyglutamine diseases. In this review, we discuss the structure and function of the PQBP-1 protein, the relevance of its aggregation and possible roles in normal and disease processes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11719261     DOI: 10.1016/s0361-9230(01)00579-2

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  7 in total

Review 1.  Molecular insights into the WW domain of the Golabi-Ito-Hall syndrome protein PQBP1.

Authors:  Marius Sudol; Caleb B McDonald; Amjad Farooq
Journal:  FEBS Lett       Date:  2012-03-28       Impact factor: 4.124

2.  Y65C missense mutation in the WW domain of the Golabi-Ito-Hall syndrome protein PQBP1 affects its binding activity and deregulates pre-mRNA splicing.

Authors:  Victor E Tapia; Emilia Nicolaescu; Caleb B McDonald; Valeria Musi; Tsutomu Oka; Yujin Inayoshi; Adam C Satteson; Virginia Mazack; Jasper Humbert; Christian J Gaffney; Monique Beullens; Charles E Schwartz; Christiane Landgraf; Rudolf Volkmer; Annalisa Pastore; Amjad Farooq; Mathieu Bollen; Marius Sudol
Journal:  J Biol Chem       Date:  2010-04-21       Impact factor: 5.157

Review 3.  PQBP1: The Key to Intellectual Disability, Neurodegenerative Diseases, and Innate Immunity.

Authors:  Hikari Tanaka; Hitoshi Okazawa
Journal:  Int J Mol Sci       Date:  2022-06-02       Impact factor: 6.208

4.  The Renpenning syndrome-associated protein PQBP1 facilitates the nuclear import of splicing factor TXNL4A through the karyopherin β2 receptor.

Authors:  Xian Liu; Lin-Xia Dou; Junhai Han; Zi Chao Zhang
Journal:  J Biol Chem       Date:  2020-02-10       Impact factor: 5.157

Review 5.  Ultra-Early Phase pathologies of Alzheimer's disease and other neurodegenerative diseases.

Authors:  Hitoshi Okazawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2017       Impact factor: 3.493

6.  Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation.

Authors:  Meihua Jin; Hiroki Shiwaku; Hikari Tanaka; Takayuki Obita; Sakurako Ohuchi; Yuki Yoshioka; Xiaocen Jin; Kanoh Kondo; Kyota Fujita; Hidenori Homma; Kazuyuki Nakajima; Mineyuki Mizuguchi; Hitoshi Okazawa
Journal:  Nat Commun       Date:  2021-11-15       Impact factor: 14.919

7.  Nematode homologue of PQBP1, a mental retardation causative gene, is involved in lipid metabolism.

Authors:  Keiko Takahashi; Sawako Yoshina; Maekawa Masashi; Wakana Ito; Takao Inoue; Hiroki Shiwaku; Hiroyuki Arai; Shohei Mitani; Hitoshi Okazawa
Journal:  PLoS One       Date:  2009-01-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.